𝔖 Bobbio Scriptorium

✦ LIBER ✦

Therapy-related myeloproliferative neoplasm withETV6-PDGFRBrearrangement following treatment of acute promyelocytic leukemia

✍ Scribed by Jean-Valère Malfuson; Johanna Konopacki; Thierry Fagot; François Desangles; Dominique Bories; Bertrand Souleau; Thierry de Revel

Book ID: 105989826
Publisher: Springer
Year: 2011
Tongue: English
Weight: 122 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1188-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy-related myelodysplastic syndrome

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: Possible role of cytarabine

✍ Cecilia Arana-Yi; AnneMarie W. Block; Sheila N. Sait; Laurie A. Ford; Maurice Ba 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Treatment of relapsing acute promyelocyt

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

✍ Thomas, X; Dombret, H; Cordonnier, C; Pigneux, A; Gardin, C; Guerci, A; Vekhoff, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Adding arabinosylcytosine to idarubicin

Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia: Abstracted from: Avvisati G, Petti M, Lo-Coco F et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study. LAP 0389 with 7 years of minimal follow-up. Blood 2002; 100 (9): 3141–6.

✍ Elihu Estey; Miguel A. Sanz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 77 KB